Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Nuvaxovid JN.1 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection vials (Novavax UK Ltd) |
| BNF code | 1404000ATBEACBY |
| Virtual Medicinal Product | Generic Nuvaxovid JN.1 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection vials |
| Name | Nuvaxovid JN.1 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection vials |
| Abbreviated name | Nuvaxovid JN.1 COVID-19 Vaccine 0.5ml dispersion inj vials |
| Supplier | Novavax UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✓ |
| Parallel import | ✗ |
| Restrictions on availability | Restricted Availability |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Nuvaxovid JN.1 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection vials (Novavax UK Ltd) 1 dose | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20250505000001, imported on 5th May 2025 at 04:58:39.